DE
RMD icon

DV Equities’s ResMed RMD Stock Holding History

DV Equities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
+7,592
New +$1.57M 0.21% 68
2025
Q4 		$49.1K Buy
+204
New +$52.2K 0.01% 360

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DV Equities's RMD Position: Q2 2026 in Review

DV Equities opened a new position in ResMed (RMD) in Q2 2026: 7,592 shares worth $1.48M. The stake represents 0.21% of the portfolio and ranks #68 among its holdings. This is a return to the name: DV Equities previously reported a position in RMD as recently as Q4 2025.

DV Equities first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • DV Equities held 7,592 shares of ResMed worth $1.48M as of Q2 2026.
  • ResMed was a new DV Equities position in Q2 2026.
  • ResMed made up 0.21% of DV Equities's portfolio in Q2 2026, its #68 holding.
  • DV Equities first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on DV Equities's 13F filing for Q2 2026, filed 14 Aug 2026.